These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 17826375)

  • 21. Comparison of safety and efficacy of sirolimus-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction.
    Newell MC; Henry CR; Sigakis CJ; Unger BT; Larson DM; Chavez IJ; Burke MN; Traverse JH; Henry TD
    Am J Cardiol; 2006 May; 97(9):1299-302. PubMed ID: 16635599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease.
    Schömig A; Dibra A; Windecker S; Mehilli J; Suárez de Lezo J; Kaiser C; Park SJ; Goy JJ; Lee JH; Di Lorenzo E; Wu J; Jüni P; Pfisterer ME; Meier B; Kastrati A
    J Am Coll Cardiol; 2007 Oct; 50(14):1373-80. PubMed ID: 17903638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of drug-eluting stents on intermediate angiographic and clinical outcomes in diabetic patients: insights from randomized clinical trials.
    Kumbhani DJ; Bavry AA; Kamdar AR; Helton TJ; Bhatt DL
    Am Heart J; 2008 Apr; 155(4):640-7. PubMed ID: 18371470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis.
    Airoldi F; Briguori C; Iakovou I; Stankovic G; Biondi-Zoccai G; Carlino M; Chieffo A; Montorfano M; Cosgrave J; Michev I; Rogacka R; Sangiorgi GM; Colombo A
    Am J Cardiol; 2006 Apr; 97(8):1182-7. PubMed ID: 16616023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents.
    Spaulding C; Daemen J; Boersma E; Cutlip DE; Serruys PW
    N Engl J Med; 2007 Mar; 356(10):989-97. PubMed ID: 17296825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and angiographic outcomes after placement of multiple overlapping drug-eluting stents in diffuse coronary lesions.
    Lee CW; Park KH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Am J Cardiol; 2006 Oct; 98(7):918-22. PubMed ID: 16996874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis.
    Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Sabaté M; Valgimigli M; Frati G; Kedhi E; Smits PC; Kaiser C; Genereux P; Galatius S; Kirtane AJ; Stone GW
    J Am Coll Cardiol; 2013 Aug; 62(6):496-504. PubMed ID: 23747778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sirolimus-eluting stent implantation in ST-elevation acute myocardial infarction: a clinical and angiographic study.
    Saia F; Lemos PA; Lee CH; Arampatzis CA; Hoye A; Degertekin M; Tanabe K; Sianos G; Smits PC; McFadden E; Hofma SH; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW
    Circulation; 2003 Oct; 108(16):1927-9. PubMed ID: 14557354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials.
    Dibra A; Kastrati A; Alfonso F; Seyfarth M; Pérez-Vizcayno MJ; Mehilli J; Schömig A
    J Am Coll Cardiol; 2007 Feb; 49(5):616-23. PubMed ID: 17276188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2-year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry).
    Kaltoft A; Jensen LO; Maeng M; Tilsted HH; Thayssen P; Bøttcher M; Lassen JF; Krusell LR; Rasmussen K; Hansen KN; Pedersen L; Johnsen SP; Sørensen HT; Thuesen L
    J Am Coll Cardiol; 2009 Feb; 53(8):658-64. PubMed ID: 19232897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation.
    Stone GW; Ellis SG; Colombo A; Dawkins KD; Grube E; Cutlip DE; Friedman M; Baim DS; Koglin J
    Circulation; 2007 Jun; 115(22):2842-7. PubMed ID: 17515458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.
    Kastrati A; Mehilli J; Pache J; Kaiser C; Valgimigli M; Kelbaek H; Menichelli M; Sabaté M; Suttorp MJ; Baumgart D; Seyfarth M; Pfisterer ME; Schömig A
    N Engl J Med; 2007 Mar; 356(10):1030-9. PubMed ID: 17296823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction.
    Lemos PA; Saia F; Hofma SH; Daemen J; Ong AT; Arampatzis CA; Hoye A; McFadden E; Sianos G; Smits PC; van der Giessen WJ; de Feyter P; van Domburg RT; Serruys PW
    J Am Coll Cardiol; 2004 Feb; 43(4):704-8. PubMed ID: 14975486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Firebird sirolimus eluting stent versus bare mental stent in patients with ST-segment elevation myocardial infarction.
    Gao H; Yan HB; Zhu XL; Li N; Ai H; Wang J; Li SY; Yang D
    Chin Med J (Engl); 2007 May; 120(10):863-7. PubMed ID: 17543174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction.
    Pasceri V; Patti G; Speciale G; Pristipino C; Richichi G; Di Sciascio G
    Am Heart J; 2007 May; 153(5):749-54. PubMed ID: 17452148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-eluting stents: clinical experiences and perspectives.
    Grube E; Gerckens U; Buellesfeld L
    Minerva Cardioangiol; 2002 Oct; 50(5):469-73. PubMed ID: 12384629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of the tacrolimus drug-eluting Janus stent: a prospective two-centre registry in high-risk patients.
    Romagnoli E; Leone AM; Burzotta F; Trani C; Angeloni G; Materazzo G; Niccoli G; De Vita M; Perfetti M; Mazzari MA; Mongiardo R; Rebuzzi AG; Schiavoni G; Crea F
    J Cardiovasc Med (Hagerstown); 2008 Jun; 9(6):589-94. PubMed ID: 18475127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-eluting stents vs bare metal stents for the treatment of large coronary vessels.
    Quizhpe AR; Feres F; de Ribamar Costa J; Abizaid A; Maldonado G; Costa R; Abizaid A; Cano M; Moreira AC; Staico R; Mattos LA; Tanajura LF; Chaves A; Centemero M; Sousa AM; Sousa JE
    Am Heart J; 2007 Aug; 154(2):373-8. PubMed ID: 17643591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of clinical and angiographic outcomes after Excel bioabsorbable polymer versus Firebird durable polymer rapamycin-eluting stent for the treatment of coronary artery disease in a "real world" setting: six-month follow-up results.
    Liu HB; Xu B; Qiao SB; Yang YJ; Ma WH; Qin XW; Yao M; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Li JJ; Chen JL; Gao RL
    Chin Med J (Engl); 2007 Apr; 120(7):574-7. PubMed ID: 17442205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Promising efficacy of the sirolimus-eluting stent in patients with acute myocardial infarction].
    Gochi T; Umeda H; Yoshida N; Maekawa H; Watanabe K; Okada T; Katoh T; Asai T; Tani T; Yokoya M; Murakami Y; Matsushita T; Shimizu T; Ozaki Y; Hiramitsu S; Murohara T; Nomura M; Morimoto S; Hishida H
    J Cardiol; 2006 Nov; 48(5):253-61. PubMed ID: 17136820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.